News MustGrow Biologics Corp. Canadian Securities Exchange

Equities

MGRO

CA62822A1030

Delayed Canadian Securities Exchange Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		+6.74%	-28.57%

29/05	MustGrow Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
08/05	Mustgrow Biologics Corp. Receives California Department of Food Agriculture Registration Approval	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

MustGrow Biologics Corp. Announces Results of Shareholder Meeting	28/06	NE
MustGrow Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/05	CI
MustGrow Biologics : Presentation	16/05	PU
MustGrow Biologics Gains California Approval for Organic Biofertility Product, TerraSante	09/05	AQ
Mustgrow Biologics Corp. Receives California Department of Food Agriculture Registration Approval	08/05	CI
MustGrow Receives California Registration and Organic Approval for TerraSante(TM) Biofertility Product	08/05	NE
MustGrow Biologics Secures Distribution Agreement for TerraSante in Oregon and Washington State	03/05	AQ
MustGrow Signs Exclusive Distribution Agreement with G.S. Long Co., Inc. for TerraSante? Biofertility Product	02/05	CI
MustGrow Signs Exclusive Distribution Agreement with G.S. Long Co., Inc. for TerraSante(TM) Biofertility Product	02/05	NE
MustGrow Biologics : Year End 2023	24/04	PU
MustGrow Biologics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	24/04	CI
MustGrow Biologics to Present at the Planet MicroCap Showcase	17/04	NE
MustGrow Receives Registration Approval for TerraSante(TM) in Oregon State	06/02	NE
MustGrow Biologics Corp.(TSXV:MGRO) dropped from S&P/TSX Venture Composite Index	22/01	CI
MustGrow Provides Additional Information and Clarification on Commercial License Agreement with Bayer	13/12	NE
MustGrow Biologics agrees to commercial licence agreement with Bayer covering Europe, Middle East and Africa	12/12	AQ
Mustgrow Biologics Corp. Announces the Signing of Collaboration Agreement with Bayer AG	11/12	CI
MustGrow Biologics and Bayer Sign Commercial License Agreement for Biocontrol Technologies in Europe, Middle East and Africa	11/12	NE
MustGrow Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/11	CI
MustGrow Biologics announces company has received approval for TerraSante in Washington State	16/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News MustGrow Biologics Corp. Canadian Securities Exchange

Equities

MGRO

CA62822A1030

Summary

Filters